Deferred Tax Assets, Valuation Allowance of Astria Therapeutics, Inc. from 31 Dec 2014 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Astria Therapeutics, Inc. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2014 to 31 Dec 2024.
  • Astria Therapeutics, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2024 was $153,529,000, a 23% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

Astria Therapeutics, Inc. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $153,529,000 +$28,755,000 +23% 31 Dec 2024 10-K 11 Mar 2025 2024 FY
Q4 2023 $124,774,000 +$21,144,000 +20% 31 Dec 2023 10-K 11 Mar 2025 2024 FY
Q4 2022 $103,630,000 +$14,562,000 +16% 31 Dec 2022 10-K 04 Mar 2024 2023 FY
Q4 2021 $89,068,000 +$11,200,000 +14% 31 Dec 2021 10-K 22 Mar 2023 2022 FY
Q4 2020 $77,868,000 +$11,107,000 +17% 31 Dec 2020 10-K 10 Mar 2022 2021 FY
Q4 2019 $66,761,000 +$7,584,000 +13% 31 Dec 2019 10-K/A 19 Apr 2021 2020 FY
Q4 2018 $59,177,000 +$7,762,000 +15% 31 Dec 2018 10-K 10 Mar 2020 2019 FY
Q4 2017 $51,415,000 -$8,426,000 -14% 31 Dec 2017 10-K 14 Mar 2019 2018 FY
Q4 2016 $59,841,000 +$14,671,000 +32% 31 Dec 2016 10-K 15 Mar 2018 2017 FY
Q4 2015 $45,170,000 +$13,647,000 +43% 31 Dec 2015 10-K 16 Mar 2017 2016 FY
Q4 2014 $31,523,000 31 Dec 2014 10-K 15 Mar 2016 2015 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.